Cardioprotective Effects of the 4-Week Aerobic Running Exercises Before Treatment with Doxorubicin in Rats.
Autor: | Pereira TCR; Experimental Medicine Laboratory, Department of Medicine, Universidade Federal de Uberlândia-UFU, Uberlândia, MG, Brazil. talitaedf@hotmail.com.; Uberlândia, Brazil. talitaedf@hotmail.com., Fidale TM; Department of Medicine, Federal University of Catalão- UFCAT, Catalão-Goiás, Brazil., Guimarães LC; Experimental Medicine Laboratory, Department of Medicine, Universidade Federal de Uberlândia-UFU, Uberlândia, MG, Brazil., Deconte SR; Department of Physiology, Institute of Biomedical Sciences, Universidade Federal de Uberlândia-UFU, Uberlândia, MG, Brazil., Herrera GC; Veterinary Hospital Universidade Federal de Uberlândia, Uberlândia, MG, Brazil., Mundim AV; Veterinary Medicine, Universidade Federal de Uberlândia-UFU, Uberlândia, MG, Brazil., de Sales Cabral E; Experimental Medicine Laboratory, Department of Medicine, Universidade Federal de Uberlândia-UFU, Uberlândia, MG, Brazil., Lopes PR; Department of Physiology and Pathology, School of Dentistry-FOAr, Paulista State University 'Julio de Mesquita Filho'-UNESP, Araraquara, SP, Brazil., de Souza FR; Experimental Medicine Laboratory, Department of Medicine, Universidade Federal de Uberlândia-UFU, Uberlândia, MG, Brazil., de Ulhôa Rocha Júnior LD; Experimental Medicine Laboratory, Department of Medicine, Universidade Federal de Uberlândia-UFU, Uberlândia, MG, Brazil., Silva ATF; Laboratory of Nanobiotechnology, Institute of Genetics and Biochemistry, Luiz Ricardo Goulart Filho, Universidade Federal de Uberlândia-UFU, Prof. Dr, Uberlândia, MG, Brazil., Resende ES; Graduate Program in Health Sciences-PPGCS, Faculty of Medicine, Universidade Federal de Uberlândia-UFU, Uberlândia, MG, Brazil. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cardiovascular toxicology [Cardiovasc Toxicol] 2023 Aug; Vol. 23 (7-8), pp. 265-277. Date of Electronic Publication: 2023 Jul 04. |
DOI: | 10.1007/s12012-023-09798-2 |
Abstrakt: | Doxorubicin is associated with cardiotoxicity, and physical exercise seeks to minimize the toxic effects of doxorubicin through physiological cardiac remodeling, as well as the reduction of oxidative stress, evidenced by previous studies. This study aimed to analyze whether running training before treatment with doxorubicin influences tolerance to physical exertion and cardiotoxicity. Thirty-nine male Wistar rats, aged 90 days and weighing between 250 and 300 g, were divided into 4 groups: Control (C), Doxorubicin (D), Trained (T), and Trained + Doxorubicin (TD). Animals in groups T and DT were submitted to treadmill running for 3 weeks, 5 times a week at 18 m/min for 20-30 min before treatment with doxorubicin. Animals in groups D and DT received intraperitoneal injections of doxorubicin hydrochloride three times a week for two weeks, reaching a total cumulative dose of 7.50 mg/kg. Our results show an increase in total collagen fibers in the D group (p = 0.01), but no increase in the TD group, in addition to the attenuation of the number of cardiac mast cells in the animals in the TD group (p = 0.05). The animals in the TD group showed maintenance of tolerance to exertion compared to group D. Therefore, running training attenuated the cardiac damage caused by the treatment with doxorubicin, in addition to maintaining the tolerance to exertion in the rats. (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.) |
Databáze: | MEDLINE |
Externí odkaz: |